Search

Armata Pharmaceuticals has addressed its shareholders with good news about how their company is progressing post-merger between C3J and AmpliPhi. The company also recently announced that it has received a Research and Development Tax Incent

Krystyna Dąbrowska (Polish Academy of Sciences) and Stephen Abedon (Ohio State University) have published a review on what it means to do "pharmacologically aware" phage therapy, which takes into consideration the in vivo obstacles to phage

If you can get to Hamilton, Ontario Nov 14-15, check out the 2019 Gairdner Symposium: Fuelling the Fight Against Antimicrobial Resistance. Speakers include Dame Sally Davies (UK special envoy on AMR), Kevin Outterson (Director of CarbX), au

Why do bacteria evolve CRISPR-based phage resistance in natural environments, while in the lab, they seem to more readily evolve receptor-based resistance? Ellinor Alseth (University of Exeter) and colleagues have published a new paper digg

Engineering phages is getting more popular; here's another breakthrough in phage synthetic biology! Matthew Dunne (ETH Zurich) and colleagues have developed several approaches for engineering phages targeting Gram-positive pathogens (using

Is lyophilization a good way to store phages? Prasanth Manohar and Nachimuthu Ramesh (Vellore Institute of Technology) tested lyophilization conditions for three phages (an Escherichia phage, a Klebsiella phage and an Enterobacter phage) us

Another publicly-traded phage company is now on the stock market! This week, the phage/microbiome biotech company BiomX completed its merger with Chardan Healthcare, and the combined company (BiomX Inc.) started trading on the New York Stoc

Another publicly-traded phage company is now on the stock market! This week, the phage/microbiome biotech company BiomX completed its merger with Chardan Healthcare, and the combined company (BiomX Inc.) started trading on the New York Stoc

Why do bacteria evolve CRISPR-based phage resistance in natural environments, while in the lab, they seem to more readily evolve receptor-based resistance? Ellinor Alseth (University of Exeter) and colleagues have published a new paper digg

Engineering phages is getting more popular; here's another breakthrough in phage synthetic biology! Matthew Dunne (ETH Zurich) and colleagues have developed several approaches for engineering phages targeting Gram-positive pathogens (using

Is lyophilization a good way to store phages? Prasanth Manohar and Nachimuthu Ramesh (Vellore Institute of Technology) tested lyophilization conditions for three phages (an Escherichia phage, a Klebsiella phage and an Enterobacter phage) us

Jeffrey Carey (University of Pennsylvania) and colleagues have shown that a temperate E. coli phage reprograms its host's regulation of an anaerobic respiratory system. They found that the prophage disables the bet-hedging strategy that aid

Amelia McKitterick and Sian Owen, Boston, Massachussetts Calling all phage enthusiasts in the Boston area! @implosian and I want to organize a meetup with other Boston phage peeps to share ideas and network etc. Trying to gauge interest, so

Amelia McKitterick and Sian Owen, Boston, Massachussetts Calling all phage enthusiasts in the Boston area! @implosian and I want to organize a meetup with other Boston phage peeps to share ideas and network etc. Trying to gauge interest, so

Jeffrey Carey (University of Pennsylvania) and colleagues have shown that a temperate E. coli phage reprograms its host's regulation of an anaerobic respiratory system. They found that the prophage disables the bet-hedging strategy that aid

We collectively don’t know much about how phages work in cocktails, or how best to optimize phage therapy when multiple phages are combined. Rosanna Wright (University of York) and colleagues have shown, using P. aeruginosa and pairs of pha

Marta Lourenço (Institut Pasteur) and colleagues have published a preprint on how inaccessible sites in the mouse gut mucosa serve as a spatial refuge for bacteria, limiting phage predation, and leading to phage-bacterial coexistence that i

There’s been lots of talk recently about communication between virus-infected bacterial cells, but it’s actually an old phenomenon. Stephen Abedon (Ohio State University) has published a new review on the history of lysis inhibition, “the G

PhagoMed has announced it will develop a phage lysin for bacterial vaginosis (targeting Gardnerella vaginalis). This means the company is extending its portfolio, as prior to this it was only working on complete phages. Press Release | News

The European Court of Justice has issued a Court Order that enables food companies to continue the use of phages to prevent Listeria on all ready to eat foods in the EU in the absence of a legal EU framework. Using Listeria phages on food h